Market Research Reports and Industry Reports

Germany Immuno Chemistry Market Outlook to 2024

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Germany Immuno Chemistry Market Outlook to 2024

Summary

GlobalDatas new report, Germany Immuno Chemistry Market Outlook to 2024, provides key market data on the Germany Immuno Chemistry market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Complement Deficiency Tests, Diabetes Assays, Disease Specific Immunochemistry, Endocrinology Tests, IgE Allergy Blood Tests, Immunochemistry Analyzers, Immunochemistry Rapid Tests & POC and Vitamins Tests

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Immuno Chemistry market segments - Complement Deficiency Tests, Diabetes Assays, Disease Specific Immunochemistry, Endocrinology Tests, IgE Allergy Blood Tests, Immunochemistry Analyzers, Immunochemistry Rapid Tests & POC and Vitamins Tests.
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.
- 2017 company shares and distribution shares data for each of the market segments.
- Global corporate-level profiles of key companies operating within the Germany Immuno Chemistry market.
- Key players covered include Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Abbott Laboratories and Thermo Fisher Scientific Inc.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution - Identify, understand and capitalize.

2
1.List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.What Is This Report About? 7
2.2 Immuno Chemistry Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 9
3 Immuno Chemistry Market, Germany 13
3.Immuno Chemistry Market, Germany, Revenue ($m), 2010-2017 13
3.2 Immuno Chemistry Market, Germany, Revenue ($m), 2017-2024 15
3.2.Complement Deficiency Tests Market, Germany, Revenue ($m), by Segment, 2010-2017 17
3.2.2 Diabetes Assays Market, Germany, Revenue ($m), by Segment, 2010-2017 19
3.2.3 Disease Specific Immunochemistry Market, Germany, Revenue ($m), by Segment, 2010-2017 21
3.2.4 Endocrinology Tests Market, Germany, Revenue ($m), by Segment, 2010-2017 23
3.2.5 IgE Allergy Blood Tests Market, Germany, Revenue ($m), by Segment, 2010-2017 25
3.2.6 Immunochemistry Analyzers Market, Germany, Revenue ($m), by Segment, 2010-2017 27
3.2.7 Immunochemistry Rapid Tests & POC Market, Germany, Revenue ($m), by Segment, 2010-2017 29
3.2.8 Vitamins Tests Market, Germany, Revenue ($m), by Segment, 2010-2017 31
3.2.9 Complement Deficiency Tests Market, Germany, Revenue ($m), by Segment, 2017-2024 33
3.2.10 Diabetes Assays Market, Germany, Revenue ($m), by Segment, 2017-2024 35
3.2.1Disease Specific Immunochemistry Market, Germany, Revenue ($m), by Segment, 2017-2024 37
3.2.12 Endocrinology Tests Market, Germany, Revenue ($m), by Segment, 2017-2024 39
3.2.13 IgE Allergy Blood Tests Market, Germany, Revenue ($m), by Segment, 2017-2024 41
3.2.14 Immunochemistry Analyzers Market, Germany, Revenue ($m), by Segment, 2017-2024 43
3.2.15 Immunochemistry Rapid Tests & POC Market, Germany, Revenue ($m), by Segment, 2017-2024 45
3.2.16 Vitamins Tests Market, Germany, Revenue ($m), by Segment, 2017-2024 47
3.3 Immuno Chemistry Market, Germany, Volume (Units), 2010-2017 49
3.4 Immuno Chemistry Market, Germany, Volume (Units), 2017-2024 51
3.4.Complement Deficiency Tests Market, Germany, Volume (Units), by Segment, 2010-2017 53
3.4.2 Diabetes Assays Market, Germany, Volume (Units), by Segment, 2010-2017 55
3.4.3 Disease Specific Immunochemistry Market, Germany, Volume (Units), by Segment, 2010-2017 57
3.4.4 Endocrinology Tests Market, Germany, Volume (Units), by Segment, 2010-2017 59
3.4.5 IgE Allergy Blood Tests Market, Germany, Volume (Units), by Segment, 2010-2017 61
3.4.6 Immunochemistry Analyzers Market, Germany, Volume (Units), by Segment, 2010-2017 63
3.4.7 Immunochemistry Rapid Tests & POC Market, Germany, Volume (Units), by Segment, 2010-2017 65
3.4.8 Vitamins Tests Market, Germany, Volume (Units), by Segment, 2010-2017 67
3.4.9 Complement Deficiency Tests Market, Germany, Volume (Units), by Segment, 2017-2024 69
3.4.10 Diabetes Assays Market, Germany, Volume (Units), by Segment, 2017-2024 71
3.4.1Disease Specific Immunochemistry Market, Germany, Volume (Units), by Segment, 2017-2024 73
3.4.12 Endocrinology Tests Market, Germany, Volume (Units), by Segment, 2017-2024 75
3.4.13 IgE Allergy Blood Tests Market, Germany, Volume (Units), by Segment, 2017-2024 77
3.4.14 Immunochemistry Analyzers Market, Germany, Volume (Units), by Segment, 2017-2024 79
3.4.15 Immunochemistry Rapid Tests & POC Market, Germany, Volume (Units), by Segment, 2017-2024 81
3.4.16 Vitamins Tests Market, Germany, Volume (Units), by Segment, 2017-2024 83
3.5 Immuno Chemistry Market, Germany, Average Price ($), 2010-2024 85
3.6 Immuno Chemistry Market, Germany, Distribution Share by Revenue ($m), 2017 89
3.7 Immuno Chemistry Market, Germany, Company Share by Revenue ($m), 2017 90
4 Overview of Key Companies in Germany, Immuno Chemistry Market 92
4.F. Hoffmann-La Roche Ltd 92
4.1.Company Overview 92
4.2 Siemens Healthcare GmbH 92
4.2.Company Overview 92
4.3 Abbott Laboratories 92
4.3.Company Overview 92
4.4 Beckman Coulter Inc 92
4.4.Company Overview 92
4.5 Thermo Fisher Scientific Inc 93
4.5.Company Overview 93
4.6 bioMerieux SA 93
4.6.Company Overview 93
4.7 Bio-Rad Laboratories Inc 93
4.7.Company Overview 93
4.8 DiaSorin S.p.A 93
4.8.Company Overview 93
4.9 Diagnostic Automation/ Cortez Diagnostics Inc 94
4.9.Company Overview 94
5 Immuno Chemistry Market Pipeline Products 95
6 Financial Deals Landscape 98
6.Acquisition 98
6.1.DIAsource ImmunoAssays Acquires Viro-Immun Diagnostics 98
6.1.2 Cathay Fortune International to Acquire Epigenomics 99
6.2 Asset Transactions 101
6.2.DiaSorin to Acquire ELISA Immunodiagnostic Business Portfolio from Siemens Healthcare for USD55.3 Million 101
6.3 Debt Offerings 103
6.3.Epigenomics Raises USD8.5 Million in Private Placement of Bonds 103
6.3.2 Fresenius Raises USD742.5 Million in Private Placement of 0.875% Notes Due 2022 104
6.3.3 Fresenius Raises USD742.5 Million in Private Placement of 1.5% Notes Due 2024 105
6.3.4 Fresenius Raises USD742.5 Million in Private Placement of 2.125% Notes Due 2027 106
6.3.5 Fresenius Raises USD530.4 Million in Private Placement of 3% Notes Due 2032 107
6.4 Equity Offerings 108
6.4.Epigenomics Raises USD6.5 Million in Private Placement of Shares 108
6.4.2 Siemens Healthcare May Raise up to USD47.3 Billion in IPO 109
6.4.3 Siemens Healthcare Plans IPO of Shares 110
6.5 Partnerships 111
6.5.Singulex Enters into Agreement with Qiagen 111
7 Recent Developments 112
7.Corporate Communications 112
7.1.Aug 16, 2017: Curetis Announces Management Board Changes 112
7.1.2 Jul 21, 2017: Fresenius appoints Rachel Empey as Chief Financial Officer 112
7.1.3 May 31, 2017: apceth Biopharma appoints Dusan Kosijer as Chief Financial Officer 112
7.1.4 Apr 12, 2017: Curetis Expands Supervisory and Medical Advisory Boards 113
7.1.5 Jan 13, 2017: Fresenius Medical Care Announces Leadership Change in North America 113
7.1.6 Jan 13, 2017: Eppendorf: William Linton is new member of the Supervisory Board 114
7.2 Financial Announcements 114
7.2.Sep 01, 2017: Start of MRX-4TZT Phase I a Clinical Trial in the United States 114
7.2.2 Aug 16, 2017: Curetis Announces Financial Results for the First Six Months of 2017 115
7.2.3 Aug 02, 2017: Eckert & Ziegler: Quarterly Report II 118
7.2.4 Aug 01, 2017: Fresenius confirms its guidance after a strong second quarter with double-digit sales and earnings growth 119
7.2.5 Jul 18, 2017: ECG-Guard Helps Users to Take Control of Their Health Through an Intuitive Mobile App 121
7.2.6 Jul 06, 2017: Epigenomics issues change in guidance for financial year 2017 122
7.2.7 Jun 29, 2017: Angel Catheter Pivotal Study Published in Journal of Vascular and Interventional Radiology 122
7.2.8 May 24, 2017: Curetis Provides Business and Financial Update for the First Quarter 2017 125
7.2.9 May 10, 2017: Epigenomics announces 2017 First Quarter Financial Results 126
7.2.10 Apr 26, 2017: Epigenomics Reports Results for Financial Year 2016 127
7.2.1Apr 12, 2017: Curetis Reports Full-Year 2016 Financial Results and Updates 2017 Guidance 128
7.2.12 Nov 18, 2016: Curetis Publishes Business and Financial Update for the First Nine Months 2016 129
7.2.13 Nov 09, 2016: Epigenomics Announces 2016 Third Quarter and Nine Months Financial Results and Reports on Operational Highlights 131
7.2.14 Nov 03, 2016: Eckert & Ziegler Q3/2016: Rise in Radiopharma Segment Income keeps the Group on track, Positive outlook for 2017 132
7.3 Legal And Regulatory 132
7.3.Jan 31, 2017: Fresenius Medical Care reaches agreement on outstanding payments 132
7.4 Other Significant Developments 133
7.4.Jul 12, 2017: Fresenius Medical Care successfully amends and extends its credit agreement, ahead of schedule 133
7.4.2 Apr 28, 2017: MEDITE Cancer Diagnostics Announces Reorganization of Germany Operations 133
7.4.3 Feb 01, 2017: Streck signs distribution agreement with HiSS Diagnostics 133
7.5 Strategy And Business Planning 134
7.5.Sep 29, 2017: Fresenius lays cornerstone for new building at headquarters in Bad Homburg 134
7.5.2 Jun 08, 2017: Fresenius Medical Care sees excellent prospects for further growth and launches a new Global Efficiency Program at its Capital Markets Day 2017 134
7.5.3 Apr 06, 2017: Curetis Starts Subsidiary Ares Genetics to Advance Genetic Antibiotic Resistance Testing 135
7.5.4 Dec 08, 2016: numares Opens Singapore Subsidiary to Expand Its Diagnostic System into Asia 136
7.5.5 Nov 22, 2016: HELIOS lays foundation stone for new hospital building in Wiesbaden 137
8 Appendix 138
8.Research Methodology 139
8.1.Coverage 139
8.1.2 Secondary Research 139
8.1.3 Primary Research 140
8.1.4 Market Modeling and Forecasting 141
8.1.5 Company Share Analysis 142
8.1.6 Distribution Share Analysis 143
8.1.7 Benchmarking 143
8.2 GlobalData Consulting 143
8.3 Contact Us 144
8.4 Disclaimer 144

List Of Tables

1.1 List of Tables
Table 1: Immuno Chemistry Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 14
Table 2: Immuno Chemistry Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 16
Table 3: Complement Deficiency Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 18
Table 4: Diabetes Assays Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 20
Table 5: Disease Specific Immunochemistry Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 22
Table 6: Endocrinology Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 24
Table 7: IgE Allergy Blood Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 26
Table 8: Immunochemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 28
Table 9: Immunochemistry Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 30
Table 10: Vitamins Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 32
Table 11: Complement Deficiency Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 34
Table 12: Diabetes Assays Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 36
Table 13: Disease Specific Immunochemistry Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 38
Table 14: Endocrinology Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 40
Table 15: IgE Allergy Blood Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 42
Table 16: Immunochemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 44
Table 17: Immunochemistry Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 46
Table 18: Vitamins Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 48
Table 19: Immuno Chemistry Market, Germany, Volume (Units), Historic, 2010-2017 50
Table 20: Immuno Chemistry Market, Germany, Volume (Units), Forecast, 2017-2024 52
Table 21: Complement Deficiency Tests Market, Germany, Volume (Units), Historic, 2010-2017 54
Table 22: Diabetes Assays Market, Germany, Volume (Units), Historic, 2010-2017 56
Table 23: Disease Specific Immunochemistry Market, Germany, Volume (Units), Historic, 2010-2017 58
Table 24: Endocrinology Tests Market, Germany, Volume (Units), Historic, 2010-2017 60
Table 25: IgE Allergy Blood Tests Market, Germany, Volume (Units), Historic, 2010-2017 62
Table 26: Immunochemistry Analyzers Market, Germany, Volume (Units), Historic, 2010-2017 64
Table 27: Immunochemistry Rapid Tests & POC Market, Germany, Volume (Units), Historic, 2010-2017 66
Table 28: Vitamins Tests Market, Germany, Volume (Units), Historic, 2010-2017 68
Table 29: Complement Deficiency Tests Market, Germany, Volume (Units), Forecast, 2017-2024 70
Table 30: Diabetes Assays Market, Germany, Volume (Units), Forecast, 2017-2024 72
Table 31: Disease Specific Immunochemistry Market, Germany, Volume (Units), Forecast, 2017-2024 74
Table 32: Endocrinology Tests Market, Germany, Volume (Units), Forecast, 2017-2024 76
Table 33: IgE Allergy Blood Tests Market, Germany, Volume (Units), Forecast, 2017-2024 78
Table 34: Immunochemistry Analyzers Market, Germany, Volume (Units), Forecast, 2017-2024 80
Table 35: Immunochemistry Rapid Tests & POC Market, Germany, Volume (Units), Forecast, 2017-2024 82
Table 36: Vitamins Tests Market, Germany, Volume (Units), Forecast, 2017-2024 84
Table 37: Immuno Chemistry Market, Germany, Average Price ($) Historic, 2010-2017 85
Table 38: Immuno Chemistry Market, Germany, Average Price ($), Forecast, 2017-2024 87
Table 39: Immuno Chemistry Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2017 89
Table 40: Immuno Chemistry Market, Germany, Company Share by Revenue ($m), USD Constant, 2017 91
Table 41: Immuno Chemistry Market Pipeline Products 95
Table 42: DIAsource ImmunoAssays Acquires Viro-Immun Diagnostics 98
Table 43: Cathay Fortune International to Acquire Epigenomics 99
Table 44: DiaSorin to Acquire ELISA Immunodiagnostic Business Portfolio from Siemens Healthcare for USD55.3 Million 101
Table 45: Epigenomics Raises USD8.5 Million in Private Placement of Bonds 103
Table 46: Fresenius Raises USD742.5 Million in Private Placement of 0.875% Notes Due 2022 104
Table 47: Fresenius Raises USD742.5 Million in Private Placement of 1.5% Notes Due 2024 105
Table 48: Fresenius Raises USD742.5 Million in Private Placement of 2.125% Notes Due 2027 106
Table 49: Fresenius Raises USD530.4 Million in Private Placement of 3% Notes Due 2032 107
Table 50: Epigenomics Raises USD6.5 Million in Private Placement of Shares 108
Table 51: Siemens Healthcare May Raise up to USD47.3 Billion in IPO 109
Table 52: Siemens Healthcare Plans IPO of Shares 110
Table 53: Singulex Enters into Agreement with Qiagen 111
Table 54: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 141

Germany Rail Wheel Sensor Market Research Report 2017

The global Rail Wheel Sensor market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a

USD 3400View Report

Germany High Purity Mercury Market Research Report 2017

The global High Purity Mercury market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a

USD 3400View Report

Canada In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Canada In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology CultureGlobalDatas new report, Canada In Vitro

USD 5995View Report

Brazil In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Brazil In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology CultureGlobalDatas new report, Brazil In Vitro

USD 5995View Report

Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)


+91 9987 2952 42

CHOOSE FORMAT

  • PDF    USD 4995
  • Site Licence    USD 9990
  • Enterprise Wide Licence    USD 14985
$ 4995

Reports Details

Published Date : Nov 2017
No. of Pages :144
Country :Germany
Category :Medical Devices
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube